Related Experiment Video
Updated: Jan 25, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
BRLA-DDI: A novel framework for drug-drug interaction extraction
Zhu Yuan1, Shuailiang Zhang2, Zongjin Li3
1Department of Information Management, The National Police University for Criminal Justice, Baoding 071000, China.
Abstract:
Drug-drug interaction (DDI) extraction is a pivotal task in biomedical information processing, focused on identifying potentially adverse drug reactions (ADRs). Despite significant progress in DDI extraction, existing models struggle with complex sentence structures and ambiguous interactions, especially in cases involving rare or implicit drug relationships. To overcome these limitations, this paper presents a novel model, BRLA-DDI, that integrates BioBERT-LSTM mechanism, Relational Graph Convolutional Network (R-GCN), and a loss function incorporating attention (loss+attention) to enhance both accuracy and generalization in DDI tasks. The core innovation of BRLA-DDI lies in its synergistic integration of these components, coupled with two unique methodological contributions. First, the model employs BioBERT and BiLSTM for text feature extraction, effectively leveraging the contextual information within drug descriptions. Second, by thoroughly integrating the multihead attention mechanism with R-GCN, BRLA-DDI strengthens its capability to capture intricate relationships between drug entities. Additionally, we introduce an innovative loss-attention mechanism that merges cross-entropy loss with an attention-based regularization term, offering precise guidance for the model in learning key features during the optimization process. Lastly, we employ a dynamic negative sampling strategy that mitigates the zero-loss issue prevalent in traditional methods, thereby accelerating model convergence and enhancing robustness. Experimental results demonstrate the superiority of the proposed BRLA-DDI approach, achieving a precision of 87.68%, a recall of 88.06%, and an F1 Score of 87.87% on the DDI Extraction 2013 dataset, surpassing a wide range of existing methods. Crucially, the model also exhibits robust and superior performance on the external TAC 2018 dataset, providing compelling evidence of its strong generalizability across different data sources and annotation styles. All our code and data have been publicly released at https://github.com/Hero-Legend/LossAtt-DDI.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...